Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01946724 · ClinicalTrials.gov registry record
In-hospital and Long-term Outcomes for Percutaneous Chronic Total Coronary Occlusion Revascularization in a High-volume, Multi-operator Program
A clinical trial, sponsored by Piedmont Healthcare.
- Completed
- Registry status
- 500
- Enrollment target
NCT01946724 is a clinical trial that has completed, run by Piedmont Healthcare. The registered enrollment target is 500 participants.
The verdict
NCT01946724 has completed, sponsored by Piedmont Healthcare.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
Study Summary
The purpose of this study is to study whether percutaneous chronic total occlusion (CTO) revascularization, by the use of Percutaneous Coronary Intervention (PCI), stenting, guidewire, and catheter, improves a patient's quality of life and their left ventricular function, reduces angina severity, and improves long-term survival.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2013-08 |
| Est. Completion | 2017-05-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01946724
The ClinicalTrials.gov registry entry for NCT01946724 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Piedmont Healthcare, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01946724 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01946724 about?
NCT01946724 is a clinical study titled "In-hospital and Long-term Outcomes for Percutaneous Chronic Total Coronary Occlusion Revascularization in a High-volume, Multi-operator Program". The purpose of this study is to study whether percutaneous chronic total occlusion (CTO) revascularization, by the use of Percutaneous Coronary Intervention (PCI), stenting, guidewire, and catheter, improves a patient's quality of life and their left ventricular function, reduces angina severity, an...
What is the current status of trial NCT01946724?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2013-08. Estimated completion is 2017-05-24.
Who is sponsoring clinical trial NCT01946724?
This trial is sponsored by Piedmont Healthcare, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.